High MRPS23 expression contributes to hepatocellular carcinoma proliferation and indicates poor survival outcomes
Tumor Biology · 2017-07 · 39 (7) · 101042831770912
DOI: 10.1177/1010428317709127 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tumor Biology, online erschienen am 17.07.2017. Verfasst von Meng Pu und 9 weiteren Autor:innen. Beteiligte Einrichtung: 1 Department of Hepatobiliary Surgery, Xijing Hospital, The Fourth Military Medical University, Xi'an, China. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Hepatocellular carcinoma is one of the most prevalent neoplasms and the leading cause of cancer-related mortality worldwide. Mitochondrial ribosomal protein S23 is encoded by a nuclear gene and participates in mitochondrial protein translation. Mitochondrial ribosomal protein S23 overexpression has been found in many types of cancer. In this study, we explored mitochondrial ribosomal protein S23 expression in primary hepatocellular carcinoma tissues compared with matched adjacent non-tumoral liver tissues using mitochondrial ribosomal protein S23 messenger RNA and protein levels collected from public databases and clinical samples. Immunohistochemistry was performed to analyze the relationship between mitochondrial ribosomal protein S23 and various clinicopathological features. The results indicated that mitochondrial ribosomal protein S23 was significantly overexpressed in hepatocellular carcinoma. High mitochondrial ribosomal protein S23 expression was correlated with the tumor size and tumor–metastasis–node stage. Moreover, patients with high mitochondrial ribosomal protein S23 expression levels presented poorer survival rates. Mitochondrial ribosomal protein S23 was an independent prognostic factor for survival, especially at the early stage of hepatocellular carcinoma. In addition, the downregulation of mitochondrial ribosomal protein S23 decreased the proliferation of hepatocellular carcinoma in vitro and in vivo. In conclusion, we verified for the first time that mitochondrial ribosomal protein S23 expression was upregulated in hepatocellular carcinoma. High mitochondrial ribosomal protein S23 levels can predict poor clinical outcomes in hepatocellular carcinoma, and this protein plays a key role in tumor proliferation. Therefore, mitochondrial ribosomal protein S23 may be a potential therapeutic target for hepatocellular carcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1 Department of Hepatobiliary Surgery, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.
- 2 Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.
Zitieren
APA
Pu, M., Wang, J., Huang, Q., Zhao, G., Xia, C., Shang, R., Zhang, Z., Bian, Z., Yang, X., & Tao, K. (2017). High MRPS23 expression contributes to hepatocellular carcinoma proliferation and indicates poor survival outcomes. Tumor Biology, 39(7), 101042831770912. https://doi.org/10.1177/1010428317709127
Vancouver
Pu M, Wang J, Huang Q, Zhao G, Xia C, Shang R, et al. High MRPS23 expression contributes to hepatocellular carcinoma proliferation and indicates poor survival outcomes. Tumor Biology. 2017;39(7):101042831770912. doi:10.1177/1010428317709127
BibTeX
@article{Pu2017,
author = {Pu, Meng and Wang, Jianlin and Huang, Qike and Zhao, Ge and Xia, Congcong and Shang, Runze and Zhang, Zhuochao and Bian, Zhenyuan and Yang, Xishegn and Tao, Kaishan},
title = {High MRPS23 expression contributes to hepatocellular carcinoma proliferation and indicates poor survival outcomes},
journal = {Tumor Biology},
year = {2017},
volume = {39},
number = {7},
pages = {101042831770912},
doi = {10.1177/1010428317709127}
}
EUVIMED